Page last updated: 2024-10-26

3,4-dihydroxybenzohydroxamic acid and Hypergammaglobulinemia

3,4-dihydroxybenzohydroxamic acid has been researched along with Hypergammaglobulinemia in 1 studies

Hypergammaglobulinemia: An excess of GAMMA-GLOBULINS in the serum due to chronic infections or PARAPROTEINEMIAS.

Research Excerpts

ExcerptRelevanceReference
" However, appeal for the long-term use of HU in HIV-1 infection may be limited by its propensity to induce hematopoietic toxicity."1.31Suppression of retrovirus-induced immunodeficiency disease (murine AIDS) by trimidox and didox: novel ribonucleotide reductase inhibitors with less bone marrow toxicity than hydroxyurea. ( Ahmed, MM; Chendil, D; Elford, HL; Gallicchio, VS; Greenberg, RN; Mampuru, LJ; Mayhew, CN; Phillips, JD, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mayhew, CN1
Mampuru, LJ1
Chendil, D1
Ahmed, MM1
Phillips, JD1
Greenberg, RN1
Elford, HL1
Gallicchio, VS1

Other Studies

1 other study available for 3,4-dihydroxybenzohydroxamic acid and Hypergammaglobulinemia

ArticleYear
Suppression of retrovirus-induced immunodeficiency disease (murine AIDS) by trimidox and didox: novel ribonucleotide reductase inhibitors with less bone marrow toxicity than hydroxyurea.
    Antiviral research, 2002, Volume: 56, Issue:2

    Topics: Animals; Benzamidines; Bone Marrow Cells; DNA, Viral; Female; Femur; Free Radical Scavengers; Hemato

2002